15.06.2020 // Category:
Rodenstock successfully completes a capital increase of up to 75 mio euros
• Committment by existing shareholders underlines confidence in the Group's strategy and sustained growth
• Capital increase follows record results in 2019
• Order intake from independent opticians in most countries are nearly back at comparable level of the pre-Corona crisis period
• Focus on high-quality Biometric Intelligent Glasses (B.I.G) remains at the core of Rodenstock’s business strategy
Munich, 15 June 2020 – The Rodenstock Group, one of the worldwide leading manufacturers of high-quality ophthalmic lenses, has successfully completed a capital increase of up to 75 million euros. The funds came exclusively from the existing shareholders. The additional financial resources strengthen the liquidity and capital base of Rodenstock and support its ambitions growth objectives in the core business. The corona pandemic led to a temporary sharp drop in sales. However, business is now recovering faster than expected, especially in Germany. In-line with its business plan, Rodenstock’s continues to focus on its core competencies in the production of high-quality progressive lenses called Biometric Intelligent Glasses (B.I.G).
“The successful capital increase demonstrates the confidence of the shareholders in our strategy and our sustained growth,” said Rodenstock Group CEO Anders Hedegaard. “2019 was a record year for Rodenstock. Following a strong start to the year, the corona pandemic caused a sharp downturn; however, the business is now experiencing a rebound. In May, we have already reached an order intake from independent opticians in Germany nearly at the level of the pre-Corona crisis period. We are expecting to continue our growth path in the years to come.”
Sales of high-quality progressive lenses driving growth
The recent capital increase follows a financial year 2019 with record results. Sales grew to €450 million (previous year: €425 million) with sales growth more than doubling to 6%. Operating earnings (EBITDA) even increased by 13% to €103 million (previous year: €91 million). The EBITDA margin improved by two percentage points to a record of 23%.
Demand was particularly strong for the patented biometric measurement technology, which stands at the core of Rodenstock’s business strategy. It enables the production of high-quality progressive glasses (Biometric Intelligent Glasses) that deliver superior vision performance. The supporting businesses including eye measurement devices, services and the two frame brands Rodenstock and Porsche Design.
“We are driving a paradigm shift in progressive lenses” said Anders Hedegaard. “With our Biometric Intelligent Glasses, every consumer can see as clearly and sharply as currently possible from a technical perspective. In addition, opticians are increasingly becoming highly qualified consultants and our service meets their requirements head-on. This unique value proposition sets us and our partnering opticians apart from an extremely competitive environment and secures us a strong position in a highly attractive market.”
“Digital fingerprint” of each eye at the core of Rodenstock’s strategy
Every eye is different. That is why Rodenstock produces glasses based on an individual eye model. To this end, the company has launched the eye measurement device DNEye® scanner in 2012. It enables opticians to determine the biometrics of the whole eye by measuring thousands of data points of the consumers eye. This ultimately provides consumers with the sharpest vision possible at any angle or with every gaze, both in the glasses’ peripheral zones and at distances from mid, near and far. Rodenstock is the first lens manufacturer producing glasses built on an eye’s individual “digital fingerprint”.
The Rodenstock Group is a worldwide leading manufacturer of high-quality ophthalmic lenses. With the philosophy "B.I.G. VISION™ FOR ALL” the lens manufacturer stands for a paradigm shift in individual progressive lenses. The company, which was founded in 1877 with its headquarters in Munich, Germany, employs around 4,900 people worldwide and is represented with sales offices and distribution partners in more than 85 countries. Rodenstock maintains production plants at 14 locations in 13 countries. For more information, visit www.rodenstock.com/press.
About Compass Partners:
Compass Partners, based in London/UK and Stamford/USA, is a private equity investor founded in 1997 focused on secondary direct transactions. Compass provides bespoke and flexible solutions to create liquidity solutions for fund managers, financial institutions or corporates from legacy funds or assets. Compass has been majority shareholder of the Rodenstock Group since February 2016. For more information, visit www.cpil.co.uk.